Business Wire

Trilliant’s Corporate Commitment to Sustainability Reinforced with Certifications, Awards

28.8.2023 02:00:00 EEST | Business Wire | Press release

Share

Trilliant, a leading international provider of solutions for advanced metering infrastructure (AMI), smart grid, smart cities and IIoT, continues to focus on its commitment to sustainability for its customers and the company with new recertifications, awards and assessments.

Trilliant previously announced its Integrated Management System was recertified to ISO 9001:2015 and ISO 14001:2015. Recently, DEKRA Audits has also recertified Trilliant in the following areas, solidifying Trilliant’s commitment to sustainable business operations:

  • ISO 27001:2013 standard for information security management systems (ISMS): ISO 27001 is the world's best-known standard for ISMS and defines requirements an ISMS must meet. The standard provides companies with guidance for establishing, implementing, maintaining, and continually improving an information security management system. Conformity with ISO/IEC 27001 means that an organization or business has put in place a system to manage risks related to the security of data owned or handled by the company, and that this system respects all the best practices and principles enshrined in this International Standard.
  • ISO 45001:2018 standard for occupational health and safety (OH&S) management: ISO 45001:2018 specifies requirements for an OH&S management system. It gives guidance for its use to enable organizations to provide safe and healthy workplaces by preventing work-related injury and ill health, as well as by proactively improving its OH&S performance.

In June 2023, Trilliant was recertified for the ECORESPONSIBLE™ Certification, progressing to Level #2 (Performance). This certification in sustainable development management is part of an ongoing four-level improvement process, designed to help organizations improve their overall performance in economic, environmental, social and governance terms. By making strategic decisions regarding sustainable development through their ECORESPONSIBLE practices, organizations show their tangible contribution to sustainable development. In doing so, they reduce their ecological impact and improve their value chain.

Trilliant is also the recipient of a 2022 EcoVadis Silver medal and placed in the top 19 percent within its industry. EcoVadis has grown to become the world’s largest and most trusted provider of business sustainability ratings, creating a global network of more than 100,000+ rated companies. EcoVadis medals recognize companies that have completed the EcoVadis assessment process and demonstrated a relatively strong management system that addresses sustainability criteria, as outlined in the EcoVadis methodology. Companies must also meet specific licensing and eligibility criteria.

Trilliant’s office in Granby, Québec, was recently recognized by the City of Granby with an Environmental Recognition Award. This awards honors citizens, non-profit organizations, businesses, industries and educational institutions of the City of Granby who have made an outstanding contribution to the community and its reputation through their commitment and achievements in environmental and sustainable development matters. Trilliant was honored in the Sustainable Industry category for its ECORESPONSIBLE™ certification.

Sustainability: A key pillar of Trilliant’s strategy

Trilliant understands that not only is sustainability important for future generations, but that utilities and cities want to know their vendors and suppliers are dedicated to social responsibility. To demonstrate its commitment, Trilliant is a participating member of the UN Global Compact. The compact is a global call to action for companies to support the UN’s social development goals (SDGs). Trilliant is focused on four of those goals, which continue to guide the company’s strategy and align with its mission: affordable and clean energy; sustainable cities and communities; responsible consumption and production; and climate action.

“Our commitment to sustainability in our work has never been clearer,” said Andy White, Chairman and CEO, Trilliant. “Our certifications and awards enable Trilliant to be accountable and ensure that our goals and practices have a positive impact on our customers, partners and all our stakeholders. We’re also proud of our global team members who are energized to engage on initiatives that are aligned with the UN SDGs.”

As the company looks ahead, it has engaged COESIO — third-party sustainability experts — to finalize and support the implementation of Trilliant's Net Zero plan. Trilliant will share its progress and impact in a future update.

About Trilliant

Trilliant® empowers the global energy industry with the only device-agnostic communications platform that enables utilities and cities to deploy any application securely and reliably on one powerful network. Our purpose-built portfolio is designed to offer the power of choice, without risk of customers being “locked in” with one technology provider or meter manufacturer. We are proud to offer mission-critical solutions that support AMI, Data & Analytics, Smart Metering, Smart Grids and Smart Cities. Customers worldwide benefit from Trilliant’s unique combination of flexibility, sustainability and scalability that connects utilities and cities to the IIoT and a more strategic path to the Energy Transition. Visit us at www.trilliant.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Tracey Mitchell
tracey.mitchell@trilliant.com

Cindy Watson/Anita Wong
StrategicAmpersand
TrilliantPR@stratamp.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye